Cancer Metastasis: Biological and Clinical Aspects, Gynaecological Cancer
作者： Malcolm Adams , Bharat Jasani
关键词:
摘要: It is likely that metastasis will remain the leading cause of treatment failure and death from gynaecological cancer for forseeable future. Key to immediate improvement in outcome ensure patients receive optimum conventional management site specialist multi-disciplinary teams working on Calman-Hine principles. Such being tailored patient needs with use relevant prognostic factors. Improved treatments including cisplatin, chemoradiation appropriate cervical taxane/platinum based combination chemotherapy advanced ovarian lead improved outcome. Ovarian its stage presentation most lethal malignancy but may be one first tumour sites benefit combined novel new e.g. anti-angiogenesis therapy. remains seen whether at high risk relapse specific anti-cancer immunotherapy HPV as target.
springer.com
sci-hub.st 参考文章(187)
Dmitry I. Gabrilovich, Sorena Nadaf, Jadranko Corak, Jay A. Berzofsky, David P. Carbone, Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. Cellular Immunology. ,vol. 170, pp. 111- 119 ,(1996) , 10.1006/CIMM.1996.0140
Morris Fishbein (), Interferon treatment of human neoplasia. Advances in Cancer Research. ,vol. 46, pp. 1- 265 ,(1986) , 10.1016/S0065-230X(08)60034-2
Jordan U. Gutterman, Kalpana Mujoo, Scott C. Anderson, Daniel C. Maneval, Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma. Oncogene. ,vol. 12, pp. 1617- 1623 ,(1996)
Spinelli J, Yang N, Swenerton Kd, Hislop Tg, Boyes Da, LeRiche Jc, Ovarian carcinoma: a multivariate analysis of prognostic factors. Obstetrics & Gynecology. ,vol. 65, pp. 264- ,(1985)
K Aabo, , M Adams, P Adnitt, DS Alberts, A Athanazziou, V Barley, DR Bell, U Bianchi, G Bolis, MF Brady, HS Brodovsky, H Bruckner, M Buyse, R Canetta, V Chylak, CJ Cohen, N Colombo, PF Conte, D Crowther, JH Edmonson, C Gennatas, E Gilbey, M Gore, D Guthrie, SB Kaye, AH Laing, F Landoni, RC Leonard, C Lewis, PY Liu, C Mangioni, S Marsoni, H Meerpohl, GA Omura, MKB Parmar, J Pater, S Pecorelli, M Presti, W Sauerbrei, DV Skarlos, RV Smalley, HJ Solomon, LA Stewart, JFG Sturgeon, MHN Tattersall, JT Wharton, WW ten Bokkel Huinink, M Tomirotti, W Torri, C Trope, MM Turbow, JB Vermorken, MJ Webb, DW Wilbur, CJ Williams, E Wiltshaw, BY Yeap, Chemotherapy in advanced ovarian cancer: Four systematic meta-analyses of individual patient data from 37 randomized trials British Journal of Cancer. ,vol. 78, pp. 1479- 1487 ,(1998) , 10.1038/BJC.1998.710
S Marsoni, , V Torri, MG Valsecchi, C Belloni, U Bianchi, G Bolis, C Bonazzi, N Colombo, A Epis, G Favalli, A Gambino, F Landoni, R Maggi, S Pecorelli, S Presti, L Vassena, F Zanaboni, C Mangioni, Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG)). British Journal of Cancer. ,vol. 62, pp. 444- 450 ,(1990) , 10.1038/BJC.1990.315
AB Mitra, VVVS Murty, Mahendra Pratap, P Sodhani, RSK Chaganti, None, ERBB2 (HER2/neu) Oncogene Is Frequently Amplified in Squamous Cell Carcinoma of the Uterine Cervix Cancer Research. ,vol. 54, pp. 637- 639 ,(1994)
Alessandro D. Santin, Lymph node metastases: the importance of the microenvironment. Cancer. ,vol. 88, pp. 175- 179 ,(2000) , 10.1002/(SICI)1097-0142(20000101)88:1<175::AID-CNCR24>3.0.CO;2-F
Lance A. Liotta, Tumor Invasion and Metastases—Role of the Extracellular Matrix: Rhoads Memorial Award Lecture Cancer Research. ,vol. 46, pp. 1- 7 ,(1986)
Myroslaw M. Hreshchyshyn, Robert C. Park, John A. Blessing, Henry J. Norris, David Levy, Leo D. Lagasse, William T. Creasman, The role of adjuvant therapy in Stage I ovarian cancer American Journal of Obstetrics and Gynecology. ,vol. 138, pp. 139- 145 ,(1980) , 10.1016/0002-9378(80)90024-1